Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemiaMartin Hoyle, Gabriel Rogers, Tiffany Moxham, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 4, 2024
International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic ModelRob Hainsworth, Alexander J Thompson, Bruce Guthrie, et al.
The Cochrane Database of Systematic Reviews|May 2, 2013
Temozolomide for high grade gliomaMichael G Hart, Ruth Garside, Gabriel Rogers, et al.
Applied Health Economics and Health Policy|May 16, 2024
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screeningStuart J Wright, Ewan Gray, Gabriel Rogers, et al.
BMC Medical Research Methodology|December 3, 2022
Development and validation of paired MEDLINE and Embase search filters for cost-utility studiesWesley Hubbard, Nicola Walsh, Thomas Hudson, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Temozolomide for high grade gliomaMichael G Hart, Robert Grant, Ruth Garside, et al.
BMJ Open|July 5, 2012
Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell diseaseKofi A Anie, Hannah Grocott, Lauren White, et al.
The Cochrane Database of Systematic Reviews|March 18, 2011
Chemotherapy wafers for high grade gliomaMichael G Hart, Robert Grant, Ruth Garside, et al.
The Cochrane Database of Systematic Reviews|July 23, 2008
Chemotherapeutic wafers for High Grade GliomaMichael G Hart, Robert Grant, Ruth Garside, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2022
Immediate birth for women between 34 and 37 weeks of gestation with prolonged preterm prelabour rupture of membranes and detection of vaginal or urine group B streptococcus: an economic evaluationJeremy Dietz, Jane Plumb, Philip Banfield, et al.
Pageof 3